Immunofixation electrophoresis of serum or urine is most often ordered to evaluate a monoclonal globulin detected in a protein electrophoresis or to delineate a possible lymphoproliferative process, particularly myeloma. This procedure will characterize the specific light and heavy chain components of a monoclonal protein.
Abnormal immunological finding in serum, unspecified. R76.9 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2020 edition of ICD-10-CM R76.9 became effective on October 1, 2019. This is the American ICD-10-CM version of R76.9 - other international versions of ICD-10 R76.9 may differ.
Quantitation of immunoglobulins IgA, IgG, and IgM; IFE interpretation of heavy- and light-chain patterns; serum protein electrophoresis Special Instructions State the patient's age and clinical diagnosis on the test request form.
R76.9 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2019 edition of ICD-10-CM R76.9 became effective on October 1, 2018. This is the American ICD-10-CM version of R76.9 - other international versions of ICD-10 R76.9 may differ.
Abnormality of plasma protein, unspecified The 2022 edition of ICD-10-CM R77. 9 became effective on October 1, 2021. This is the American ICD-10-CM version of R77.
Unspecified abnormal findings in urineICD-10 code R82. 90 for Unspecified abnormal findings in urine is a medical classification as listed by WHO under the range - Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified .
Screening is the testing for disease or disease precursors in asymptomatic individuals so that early detection and treatment can be provided for those who test positive for the disease.
Abnormal finding of blood chemistryICD-10 code: R79. 9 Abnormal finding of blood chemistry, unspecified.
Encounter for screening for other metabolic disorders Z13. 228 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM Z13. 228 became effective on October 1, 2021.
Abnormal finding of blood chemistry, unspecified The 2022 edition of ICD-10-CM R79. 9 became effective on October 1, 2021.
A screening colonoscopy should be reported with the following International Classification of Diseases, 10th edition (ICD-10) codes: Z12. 11: Encounter for screening for malignant neoplasm of the colon. Z80. 0: Family history of malignant neoplasm of digestive organs.
ICD-10 code Z13. 9 for Encounter for screening, unspecified is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .
For example, Z12. 31 (Encounter for screening mammogram for malignant neoplasm of breast) is the correct code to use when you are ordering a routine mammogram for a patient.
ICD-10 code R79. 89 for Other specified abnormal findings of blood chemistry is a medical classification as listed by WHO under the range - Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified .
ICD-9 Code Transition: 780.79 Code R53. 83 is the diagnosis code used for Other Fatigue. It is a condition marked by drowsiness and an unusual lack of energy and mental alertness. It can be caused by many things, including illness, injury, or drugs.
NCD - Partial ThromboplastinTime (PTT) (190.16)
Quantitation of serum immunoglobulins IgA, IgG, and IgM; IFE qualitative interpretation of heavy- and light-chain patterns; serum protein electrophoresis; quantitation of serum free κ and λ light chains plus κ:λ ratio
Turnaround time is defined as the usual number of days from the date of pickup of a specimen for testing to when the result is released to the ordering provider. In some cases, additional time should be allowed for additional confirmatory or additional reflex tests. Testing schedules may vary.
Sample should be allowed to clot and the serum separated as soon as possible to prevent hemolysis.
Electrophoresis followed by immunodiffusion against monospecific antisera to immunoglobulin and individual heavy and light chains (IFE); protein electrophoresis on agarose media; turbidimetric quantitation of IgA, IgG, and IgM; turbidimetric quantitation of free κ and λ light chains
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines™) recommend the use of serum free light chain assays in the initial diagnostic work-up of multiple myeloma and related disorders.
1. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines™) for Multiple Myeloma, Version 1.2011. Fort Washington, Pa: NCCN; 2011.
Abnormality of plasma protein, unspecified 1 R77.9 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. 2 The 2021 edition of ICD-10-CM R77.9 became effective on October 1, 2020. 3 This is the American ICD-10-CM version of R77.9 - other international versions of ICD-10 R77.9 may differ.
The 2022 edition of ICD-10-CM R77.9 became effective on October 1, 2021.
The 2022 edition of ICD-10-CM D47.2 became effective on October 1, 2021.
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere.
A laboratory test result indicating the presence of an abnormally high level of monoclonal immunoglobulins in the blood or urine.
Ordering Restrictions may apply. Please provide SERVICE AREA INFORMATION to find available tests you can order.
Protein, Total and Protein Electrophoresis with Immunofixation (IFE), Serum - Serum protein electrophoresis (SPE) is an analytical technique that provides separation of serum protein into six fractions: Albumin, Alpha-1, Alpha-2, Beta-1, Beta-2, and Gamma.
Please visit our Clinical Education Center to stay informed on any future publications, webinars, or other education opportunities.
Turnaround time is defined as the usual number of days from the date of pickup of a specimen for testing to when the result is released to the ordering provider. In some cases, additional time should be allowed for additional confirmatory or additional reflex tests. Testing schedules may vary.
Immunofixation electrophoresis of serum or urine is most often ordered to evaluate a monoclonal globulin detected in a protein electrophoresis or to delineate a possible lymphoproliferative process, particularly myeloma. This procedure will help identify the specific light and heavy chain components of a monoclonal protein.